A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.
- DOI
- 10.1080/14756366.2026.2704735
- Published
- 2026 Dec
- Container
- Journal of enzyme inhibition and medicinal chemistry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14756366.2026.2704735,
title = {A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.},
author = {Bai YR and Li R and Zhang XH and Seng DJ and Xu Y and Zhang SY and Yuan S},
year = {2026},
journal = {Journal of enzyme inhibition and medicinal chemistry},
doi = {10.1080/14756366.2026.2704735},
url = {https://doi.org/10.1080/14756366.2026.2704735}
}RIS
TY - JOUR TI - A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect. AU - Bai YR AU - Li R AU - Zhang XH AU - Seng DJ AU - Xu Y AU - Zhang SY AU - Yuan S PY - 2026 JO - Journal of enzyme inhibition and medicinal chemistry DO - 10.1080/14756366.2026.2704735 UR - https://doi.org/10.1080/14756366.2026.2704735 ER -
APA
YR, B., R, L., XH, Z., DJ, S., Y, X., SY, Z., & S, Y. (2026). A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.. Journal of enzyme inhibition and medicinal chemistry. https://doi.org/10.1080/14756366.2026.2704735
Source records
- pubmed · retrieved 2026-11-10T13:27:47.400Z